A New Era of Wellness: Emami's Strategic Foray into Nutraceuticals

Emami Ltd., a leading FMCG company, is poised to foray into the nutraceuticals segment with a range of scientifically researched and clinically validated products, aligning with its strategy to create new engines of growth in high-margin, high-potential categories.

Vice Chairman and MD Harsha V Agarwal stated that the company is in the process of clearing regulatory approvals to expand its healthcare portfolio into newer markets. Emami aims to develop a sharper, future-ready portfolio over the next three to five years, with diversification plans extending to health foods, nutrition, pet care, and aloe vera-based fruit juices.

As health and wellness increasingly shape consumer choices, Emami plans to offer both clean-label, eco-conscious products for urban markets and affordable, branded options for rural consumers. This strategic shift reflects the broader convergence of FMCG and nutraceuticals, driven by growing demand for preventive health solutions.

With a strong legacy of brands including Boro Plus, Navratna, Fair and Handsome, and Zandu, Emami sees significant headroom for growth in underpenetrated markets. Currently, 45% of the company’s revenues come from high-growth segments such as modern trade, e-commerce, institutional sales, international markets, and strategic subsidiaries—providing both scale and resilience to support its expansion into wellness-led categories.

News by Rahul Yelligetti.